The blockade of CD47-SIRPα interactions has been shown to enhance the phagocytic activity of phagocytes, such as macrophages, toward tumor cells, thereby resulting in the efficient eradication of tumor cells [14]. The gene discussed is SIRPA; the disease is neoplasm.